Unilever Q3 USG 5.2%, Upgrades Full-Year Volume Outlook to at Least 3%

summarizeSummary

Unilever posted Q3 2026 underlying sales growth of 5.2% on 2.9% volume and €13.3bn turnover, and raised its full-year volume growth outlook to at least 3%. The McCormick Foods combination remains on track pending regulatory and shareholder approvals.

check_boxKey Events · Earnings and Guidance · UL

• Q3 Sales Growth of 5.2%

  Underlying sales growth was 5.2%, split 2.9% volume and 2.3% price, on turnover of €13.3bn, up 6.7% versus Q3 2025.

• Full-Year Volume Outlook Upgraded

  Management now expects at least 3% underlying volume growth for full year 2026 and second-half underlying sales growth of around 5%, with USG within the 4% to 6% range.

• Foods Remains the Weak Spot

  Foods USG was 0.1% with volume down 1.1%; developed markets fell 0.9% and Europe 1.7%, offset by emerging markets at 9.5% USG led by India.

• McCormick Combination on Track

  Regulatory filings were submitted on schedule and Works Council consultation is targeted to complete before closing; the deal still needs McCormick shareholder approval and required regulatory clearances.

auto_awesomeAnalysis · UL · Industrial Applications And Services

Volume, not price, drove Unilever's 5.2% underlying sales growth in Q3 2026, with 2.9% coming from volume — a mix that signals real demand rather than inflation pass-through. Management raised full-year volume guidance to at least 3% and guided second-half USG to around 5%, a modest but real lift to the trajectory. The weak spot is Foods, flat at 0.1% USG with volume down 1.1% and developed-market retail soft — the same business being combined with McCormick, where regulatory filings are on schedule and closing now hinges on McCormick shareholder approval and Works Council consultation. A €0.4664 quarterly dividend, up 3.0% year on year, provides a steady capital-return signal alongside the ongoing buyback programs.